Figure 5
Expression of LlWOX9 and LlWOX11 after treatment with 6-BA and type-B LlRR silencing. A, Expression of LlWOX9 and LlWOX11 after treatment with 4-μM 6-BA during bulbil formation. Values are means ± sd (n = 3). Asterisks indicate significantly different values (Student’s t test, *P < 0.05 and **P < 0.01). B, Expression of LlWOX9 and LlWOX11 in leaf axils at stage S4 after 10-mM 6-BA treatment. Values are means ± sd (n = 3). Asterisks indicate significantly different values (Student’s t test, *P < 0.05 and **P < 0.01). C, Expression of LlWOX9 and LlWOX11 after type-B LlRR silencing. Values are means   sd (n = 3). Lowercase letters indicate significantly different values (Student’s t test, P < 0.05).

Expression of LlWOX9 and LlWOX11 after treatment with 6-BA and type-B LlRR silencing. A, Expression of LlWOX9 and LlWOX11 after treatment with 4-μM 6-BA during bulbil formation. Values are means ± sd (n = 3). Asterisks indicate significantly different values (Student’s t test, *P < 0.05 and **P < 0.01). B, Expression of LlWOX9 and LlWOX11 in leaf axils at stage S4 after 10-mM 6-BA treatment. Values are means ± sd (n = 3). Asterisks indicate significantly different values (Student’s t test, *P < 0.05 and **P < 0.01). C, Expression of LlWOX9 and LlWOX11 after type-B LlRR silencing. Values are means   sd (n = 3). Lowercase letters indicate significantly different values (Student’s t test, P < 0.05).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close